Survey: Over a third of Americans worry about the “tripledemic” of respiratory illnesses

Astel­las won ap­proval in Japan for Vy­loy, its gas­tric can­cer drug that was re­ject­ed by the FDA in Jan­u­ary over man­u­fac­tur­ing is­sues. Vy­loy, al­so known

Plus, news about Imag­ine Phar­ma. Galera to seek ‘strate­gic al­ter­na­tives’ af­ter FDA re­jec­tion: The com­pa­ny said Tues­day that the FDA asked for an­oth­er Phase III

I2o Ther­a­peu­tics CEO Kurt Graves set out on Thurs­day to make a case to a pan­el of the FDA’s ex­pert ad­vi­sors that the ben­e­fits of